Results 241 to 250 of about 63,333 (299)

The role of blood-based biomarkers in Parkinsonian disorders, Alzheimer's disease and frontotemporal dementia

Marta Campagnolo, Eleonora Fiorenzato, Giulia Musso, Valentina Misenti, Simone Cauzzo, Annachiara Cagnin, Roberta Biundo, Cinzia Bussè, Carmelo Fogliano, Stefano Mozzetta, Alessandra Codemo, Elisabetta Gasparoli, Stefania Moz, Marco Narici, Paola Pizzo, Maurizio Corbetta, Martina Montagnana, Angelo Antonini   +17 more
openalex   +1 more source

Depressive Symptoms are Frequent in Atypical Parkinsonian Disorders. [PDF]

Mov Disord Clin Pract, 2017
Almeida L, Ahmed B, Walz R, De Jesus S, Patterson A, Martinez-Ramirez D, Vaillancourt D, Bowers D, Ward H, Okun MS, McFarland NR.   +10 more
europepmc   +1 more source

Deceleration Capacity as a Marker of Autonomic Cardiac Modulation in Prodromal and Manifest Parkinson's Disease, Multiple System Atrophy, and Progressive Supranuclear Palsy

European Journal of Neurology, Volume 32, Issue 11, November 2025.
Objective: Heart rate variability (HRV) is a promising tool for autonomic dysfunction assessment, especially Deceleration capacity (DC), a sensitive parasympathetic marker. M&M: Study in patients with isolated REM sleep behavior disorder, Parkinson's disease, multiple system atrophy, and supranuclear palsy as compared to healthy control subjects ...
Elisabeth Ruppert, Nuria Mix, Karl Kesper, Axel Bauer, David Vadasz, Vincent Ries, Elisabeth Sittig, Ulrich Koehler, Annette Janzen, Wolfgang H. Oertel   +9 more
wiley   +1 more source

Can simple home-based exercises reduce the fear of falling in Parkinsonian disorders?

Rosy Neupane, Prashanth Lingappa Kukkle
openalex   +1 more source

Aberrant Mitochondrial Metabolism in Alzheimer's Disease Links Energy Stress with Ferroptosis

Advanced Science, Volume 12, Issue 37, October 6, 2025.
Alves et al. reveal how energy loss and oxidative stress, two major features of Alzheimer's disease, are connected. Mitochondria controls the flux of the antioxidant glutathione (GSH), via facilitating both its production and consumption. Energy restriction limits GSH synthesis, conferring vulnerability to cell death by ferroptosis, implicated as a ...
Francesca Alves, Darius Lane, Adam Wahida, Md. Jakaria, Pawel Kalinowski, Adam Southon, Abdel Ali Belaidi, Teresa Samperi‐Esteve, Triet Phu Minh Nguyen, Peng Lei, Marcus Krueger, Stefan Mueller, Marcus Conrad, Puja Agarwal, Sue E Leurgans, Julie Schneider, Ashley I. Bush, Scott Ayton   +17 more
wiley   +1 more source

Utility of susceptibility-weighted imaging in Parkinson's disease and atypical Parkinsonian disorders. [PDF]

Transl Neurodegener, 2016
Wang Z, Luo XG, Gao C.
europepmc   +1 more source

Towards optimizing the diagnosis of Lewy body dementia: Lessons from the NACC

Alzheimer's &Dementia, Volume 21, Issue 10, October 2025.
Abstract INTRODUCTION The diverse presentations and co‐pathologies of Lewy body dementia (LBD) present a diagnostic challenge. Utilizing the National Alzheimer's Coordinating Center (NACC) dataset, this study aimed to evaluate the concordance of premorbid diagnoses of LBD in individuals with autopsy‐confirmed neocortical Lewy body disease.
Anna E. Goodheart, Tess L. Brazier, Rong Ye, Patrick Stancu, Stephen N. Gomperts   +4 more
wiley   +1 more source

APOE ε4 linked effects on clinical features and neuropathology in dementia with Lewy bodies

Alzheimer's &Dementia, Volume 21, Issue 10, October 2025.
Abstract INTRODUCTION Apolipoprotein E (APOE) ε4 is a strong genetic risk factor for Alzheimer's disease (AD) neuropathologic changes, but its contribution to clinical features and pathology in dementia with Lewy bodies (DLB) is less clear. METHODS Using the National Alzheimer Coordinating Center dataset, we investigated APOE ε4‐associated effects on ...
Rong Ye, Anna E. Goodheart, Joseph J. Locascio, Erin C. Peterec, Patrick Stancu, Yanhong Wang, Stephen N. Gomperts   +6 more
wiley   +1 more source

Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders. [PDF]

Proteomics Clin Appl, 2017
Sjödin S, Hansson O, Öhrfelt A, Brinkmalm G, Zetterberg H, Brinkmalm A, Blennow K.   +6 more
europepmc   +1 more source

CSF α-synuclein does not differentiate between parkinsonian disorders

, 2011
M. Aerts, Rianne A.J. Esselink, Wilson F. Abdo, B.R. Bloem, Marcel M. Verbeek   +4 more
openalex   +1 more source